Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported

被引:43
|
作者
Card, Timothy R. [1 ,2 ]
Langan, Sinead M. [3 ]
Chu, Thomas P. C. [1 ]
机构
[1] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham, England
[2] Univ Nottingham, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham, England
[3] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England
关键词
Inflammatory bowel diseases; Epidemiology; Arthritis; Iritis; Pyoderma; PRACTICE RESEARCH DATABASE; EXTRAINTESTINAL MANIFESTATIONS; ULCERATIVE-COLITIS; ASSOCIATION; FREQUENCY; VALIDITY; RISK;
D O I
10.1007/s10620-016-4195-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Extra-intestinal manifestations are well recognized in inflammatory bowel disease (IBD). To what extent the commonly recognized extra-intestinal manifestations seen in IBD patients are attributable to IBD is, however, not clear due to the limited number of controlled studies published. We have conducted a study of these manifestations using electronic primary care records. We have identified extra-intestinal manifestations in IBD and non-IBD patients and derived odds ratios (ORs) using conditional logistic regression. A total of 56,097 IBD patients (32.5 % Crohn's disease, 48.3 % ulcerative colitis (UC) and 19.2 % not classified) were matched to 280,382 non-IBD controls. We found records of pyoderma gangrenosum (OR = 29.24), erythema nodosum (OR = 5.95), primary sclerosing cholangitis (OR = 188.25), uveitis (OR = 2.81), ankylosing spondylitis (OR = 7.07), sacroiliitis (OR = 2.79) and non-rheumatoid inflammatory arthritides (OR = 2.66) to be associated with IBD. One or more of these was recorded in 8.1 % of IBD patients and 2.3 % of controls. Non-specific arthritides were present in many more patients, affecting 30 % of IBD patients and 23.8 % of controls overall. We also found weaker associations with a number of conditions not generally considered to be extra-intestinal manifestations including psoriasis, ischemic heart disease, multiple sclerosis and hay fever. Although "classical" extra-intestinal manifestations are strongly associated with IBD, most IBD patients remain unaffected. Arthropathies, perceived to be the commonest extra-intestinal manifestation, are not strongly associated with IBD, and the proportion of arthropathies attributable to IBD is likely to be small.
引用
收藏
页码:2619 / 2626
页数:8
相关论文
共 50 条
  • [31] TAKOTSUBO CARDIOMYOPATHY MAY BE MORE COMMON THAN PREVIOUSLY REPORTED IN POSTMENOPAUSAL WOMEN PRESENTING AS ACS
    Sy, Fridolin T.
    Basraon, Jagroop
    Zheng, Hong
    Singh, Manminder
    Ambrose, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E52 - E52
  • [32] Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes
    Jansen, Fenna M.
    Vavricka, Stephan R.
    den Broeder, Alfons A.
    de Jong, Elke M. G. J.
    Hoentjen, Frank
    van Dop, Willemijn A.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (09) : 1031 - 1044
  • [33] Patient Awareness of Extra intestinal Manifestations of Inflammatory Bowel Disease in Riyadh, Saudi Arabia
    Aldosari, Mosfer S.
    AlOtaibi, Fahad F.
    AlHuzaimi, Abdullah M.
    Khalil, Noha K.
    Faden, Nourah A.
    Thaniah, Salem Y.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES, 2018, 7 (01): : 72 - 79
  • [34] Ustekinumab for Extra-intestinal Manifestations of Inflammatory Bowel Disease: A Systematic Literature Review
    Guillo, Lucas
    D'Amico, Ferdinando
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (07): : 1236 - 1243
  • [35] Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease
    Barclay, M. L.
    Stamp, L. K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 535 - 536
  • [36] PREVALENCE OF INFLAMMATORY EXTRA-INTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE IN PATIENTS TAKING BIOLOGICAL MEDICATION
    Tay, Joshua Jun Ming
    Yong, Shun Qi
    Nicoll, Ruairidh
    Seenan, John Paul
    GUT, 2022, 71 : A140 - A140
  • [37] Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review
    Chateau, Thomas
    Bonovas, Stefanos
    Le Berre, Catherine
    Mathieu, Nicolas
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (12): : 1569 - 1577
  • [38] Prevalence and Risk Factors of Extra Intestinal Manifestations in the Pediatric Inflammatory Bowel Disease Cohort
    Malaty, Hoda M.
    Abraham, Bincy
    Mehta, Seema
    Ferry, George D.
    GASTROENTEROLOGY, 2012, 142 (05) : S666 - S666
  • [39] Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases
    Guillo, Lucas
    Abreu, Maria
    Panaccione, Remo
    Sandborn, William J.
    Azevedo, Valderilio F.
    Gensler, Lianne
    Moghaddam, Bahar
    Ahuja, Vineet
    Ali, Sabrina A.
    Allez, Matthieu
    Ananthakrishnan, Ashwin N.
    Bhattacharya, Abhik
    Dubinsky, Marla
    Griffiths, Anne
    Hart, Ailsa
    Korelitz, Burton
    Kotze, Paulo G.
    Koutroubakis, Iommaso E.
    Lakatos, Peter L.
    Lindsay, James O.
    Magro, Fernando
    Mantzaris, Gerassimos J.
    Ng, Slew C.
    O'Morain, Cohn
    Panes, Julian
    Parigi, Tom Maso
    Ran, Zhihua
    Rogler, Gerhard
    Rubin, David T.
    Sachar, David B.
    Siegmund, Britta
    Steinwurz, Flavio
    Tysk, Curt
    Vavricka, Stephan
    Verstraete, Sofa G.
    Brezin, Antoine P.
    Haemel, Anna K.
    Dignass, Axel
    Sands, Bruce E.
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (03): : 254 - 261
  • [40] Inflammatory Bowel Disease Is More Common Than Earlier Studies Showed
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (24): : 2590 - 2590